Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013
In a decisive move to safeguard public health, Missouri has announced a ban on the sale of Delta-8 THC and other hemp-derived intoxicants, effective September 1. This prohibition targets products such as drinks, candy, and other edibles infused with these substances, which have surged in popularity but remain largely unregulated. State officials expressed concerns over
READ MORECannabidiol (CBD), a non-psychoactive compound found in cannabis, is gaining attention for its potential to alleviate symptoms of ulcerative colitis (UC), a chronic inflammatory bowel disease. Some studies suggest CBD may help reduce inflammation and improve quality of life for UC patients, though the evidence remains inconclusive. Keith Sharkey, Ph.D., from the University of Calgary,
READ MOREA groundbreaking study by researchers from Charles Darwin University (CDU) and the Royal Melbourne Institute of Technology (RMIT) has revealed that a specific cannabis extract, known as PHEC-66, has a “deadly” effect on melanoma cells in laboratory settings. Published in the Cells journal, the study highlights how PHEC-66 induces apoptosis, or programmed cell death, in melanoma cells,
READ MORERecent studies have shed light on the potential benefits of CBD oil in managing anxiety disorders, which affect millions of Americans annually. According to a comprehensive review published in Medical News Today, CBD has demonstrated promising results in alleviating symptoms associated with various anxiety conditions, including generalized anxiety disorder and social anxiety disorder. Researchers highlight
READ MOREAs the use of medical cannabis rises among adults aged 65 and over, a recent study reveals that older patients report substantial benefits from these products. The observational study, published in Drugs & Aging, analyzed data from 198 patients aged 65 and older who used medicinal cannabinoids, either in flower or oil extract form. The findings
READ MOREA groundbreaking study from the University of Colorado Boulder has revealed that CBD-dominant cannabis products may be more effective at reducing anxiety than THC-dominant alternatives, without the potential side effects associated with THC.The research, published in the journal Cannabis and Cannabinoid Research, involved 300 participants and is the first randomized trial to examine how commercially available
READ MORE